Business NewsPR NewsWire • Data Presented at IDWeek Highlight Risk Factors for Carbapenem Resistance Among Patients Hospitalized for Serious Infections

Data Presented at IDWeek Highlight Risk Factors for Carbapenem Resistance Among Patients Hospitalized for Serious Infections

Data Presented at IDWeek Highlight Risk Factors for Carbapenem Resistance Among Patients Hospitalized for Serious Infections

DUBLIN, Oct. 29, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company committed to research informing the treatment of infectious diseases, presented new data identifying hospitalized patients with serious infections due to Enterobactericaeae who are at...

View More : http://www.prnewswire.com/news-releases/data-presented-at-idweek-highlight-risk-factors-for-carbapenem-resistance-among-...
Releted News by prnewswire
La société Arçelik a été reconnue pour la seconde fois comme le leader mondial pour son action d'entreprise relative au changement climatique
Council of the Americas Celebrates Leadership and Innovation at the 22nd BRAVO Business Awards
Data Presented at IDWeek Highlight Risk Factors for Carbapenem Resistance Among Patients Hospitalized for Serious Infections
U.S. Census Bureau Daily Feature for October 30: Internet Birthday
Theworldsscariesthaunts.com Narrows Scariest Haunted Attractions To An Elite List of 13 To Visit This Halloween Season & Beyond